348 related articles for article (PubMed ID: 12800480)
21. The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study.
Galiatsatos P; Gibson BR; Rabiee A; Carlson O; Egan JM; Shannon RP; Andersen DK; Elahi D
Crit Care Med; 2014 Mar; 42(3):638-45. PubMed ID: 24247476
[TBL] [Abstract][Full Text] [Related]
22. Glucose control and mortality in critically ill patients.
Finney SJ; Zekveld C; Elia A; Evans TW
JAMA; 2003 Oct; 290(15):2041-7. PubMed ID: 14559958
[TBL] [Abstract][Full Text] [Related]
23. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control.
Grey NJ; Perdrizet GA
Endocr Pract; 2004; 10 Suppl 2():46-52. PubMed ID: 15251640
[TBL] [Abstract][Full Text] [Related]
24. Intensive insulin therapy in the medical ICU.
Van den Berghe G; Wilmer A; Hermans G; Meersseman W; Wouters PJ; Milants I; Van Wijngaerden E; Bobbaers H; Bouillon R
N Engl J Med; 2006 Feb; 354(5):449-61. PubMed ID: 16452557
[TBL] [Abstract][Full Text] [Related]
25. Glycemic penalty index for adequately assessing and comparing different blood glucose control algorithms.
Van Herpe T; De Brabanter J; Beullens M; De Moor B; Van den Berghe G
Crit Care; 2008; 12(1):R24. PubMed ID: 18302732
[TBL] [Abstract][Full Text] [Related]
26. Consensus recommendations for the management of hyperglycaemia in critically ill patients in the Indian setting.
Mukherjee JJ; Chatterjee PS; Saikia M; Muruganathan A; Das AK;
J Assoc Physicians India; 2014 Jul; 62(7 Suppl):16-25. PubMed ID: 25668933
[TBL] [Abstract][Full Text] [Related]
27. Intensive insulin therapy in critical care settings.
Eastman DK; Bottenberg MM; Hegge KA; Ourth H; Kabadi U
Curr Clin Pharmacol; 2009 Jan; 4(1):71-7. PubMed ID: 19149505
[TBL] [Abstract][Full Text] [Related]
28. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality.
Meyfroidt G; Keenan DM; Wang X; Wouters PJ; Veldhuis JD; Van den Berghe G
Crit Care Med; 2010 Apr; 38(4):1021-9. PubMed ID: 20124887
[TBL] [Abstract][Full Text] [Related]
29. A randomized controlled trial comparing a computer-assisted insulin infusion protocol with a strict and a conventional protocol for glucose control in critically ill patients.
Cavalcanti AB; Silva E; Pereira AJ; Caldeira-Filho M; Almeida FP; Westphal GA; Beims R; Fernandes CC; Correa TD; Gouvea MR; Eluf-Neto J
J Crit Care; 2009 Sep; 24(3):371-8. PubMed ID: 19592202
[TBL] [Abstract][Full Text] [Related]
30. The role of insulin therapy in critically ill patients.
Langouche L; Vanhorebeek I; Van den Berghe G
Treat Endocrinol; 2005; 4(6):353-60. PubMed ID: 16318401
[TBL] [Abstract][Full Text] [Related]
31. Blood glucose control in the intensive care unit: benefits and risks.
Gunst J; Van den Berghe G
Semin Dial; 2010; 23(2):157-62. PubMed ID: 20525106
[TBL] [Abstract][Full Text] [Related]
32. Impact of a Paper-Based Dynamic Insulin Infusion Protocol on Glycemic Variability, Time in Target, and Hypoglycemic Risk: A Stepped Wedge Trial in Medical Intensive Care Unit Patients.
Clergeau A; Parienti JJ; Reznik Y; Clergeau D; Seguin A; Valette X; du Cheyron D; Joubert M
Diabetes Technol Ther; 2017 Feb; 19(2):115-123. PubMed ID: 28118045
[TBL] [Abstract][Full Text] [Related]
33. Tight blood glucose control: what is the evidence?
Vanhorebeek I; Langouche L; Van den Berghe G
Crit Care Med; 2007 Sep; 35(9 Suppl):S496-502. PubMed ID: 17713399
[TBL] [Abstract][Full Text] [Related]
34. Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective.
Klonoff DC
J Diabetes Sci Technol; 2011 May; 5(3):755-67. PubMed ID: 21722591
[TBL] [Abstract][Full Text] [Related]
35. Indication and practical use of intensive insulin therapy in the critically ill.
Mebis L; Gunst J; Langouche L; Vanhorebeek I; Van den Berghe G
Curr Opin Crit Care; 2007 Aug; 13(4):392-8. PubMed ID: 17599008
[TBL] [Abstract][Full Text] [Related]
36. Clinical benefits of tight glycaemic control: focus on the intensive care unit.
Mesotten D; Van den Berghe G
Best Pract Res Clin Anaesthesiol; 2009 Dec; 23(4):421-9. PubMed ID: 20108581
[TBL] [Abstract][Full Text] [Related]
37. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control.
Robinson LE; van Soeren MH
AACN Clin Issues; 2004; 15(1):45-62. PubMed ID: 14767364
[TBL] [Abstract][Full Text] [Related]
38. Risk of Hypoglycemia During Insulin Infusion Directed by Paper Protocol Versus Electronic Glycemic Management System in Critically Ill Patients at a Large Academic Medical Center.
Rabinovich M; Grahl J; Durr E; Gayed R; Chester K; McFarland R; McLean B
J Diabetes Sci Technol; 2018 Jan; 12(1):47-52. PubMed ID: 29251064
[TBL] [Abstract][Full Text] [Related]
39. Increased hypoglycemia associated with renal failure during continuous intravenous insulin infusion and specialized nutritional support.
Dickerson RN; Hamilton LA; Connor KA; Maish GO; Croce MA; Minard G; Brown RO
Nutrition; 2011; 27(7-8):766-72. PubMed ID: 20971617
[TBL] [Abstract][Full Text] [Related]
40. Lowering of glucose in critical care: a randomized pilot trial.
McMullin J; Brozek J; McDonald E; Clarke F; Jaeschke R; Heels-Ansdell D; Leppert R; Foss A; Cook D
J Crit Care; 2007 Jun; 22(2):112-8; discussion 118-9. PubMed ID: 17548021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
